• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Expression level of augmenter of liver regeneration in patients with hepatic failure and hepatocellular carcinoma

    2010-06-29 10:13:48HaiYingYuDaiRongXiangHaiJunHuangJunLiandJiFangSheng

    Hai-Ying Yu, Dai-Rong Xiang, Hai-Jun Huang, Jun Li and Ji-Fang Sheng

    Hangzhou, China

    Expression level of augmenter of liver regeneration in patients with hepatic failure and hepatocellular carcinoma

    Hai-Ying Yu, Dai-Rong Xiang, Hai-Jun Huang, Jun Li and Ji-Fang Sheng

    Hangzhou, China

    BACKGROUND:Augmenter of liver regeneration (ALR) is an important polypeptide in the process of liver regeneration. This study aimed to determine the expression level of ALR in different liver diseases and its significance.

    METHODS:We prepared murine polyclonal antibody against ALR protein from Balb/C mice and purified the IgG fraction, which specifically combined to ALR protein as shown by Western blotting. Serum ALR levels in patients with hepatocellular carcinoma (HCC), hepatic failure (HF), chronic hepatitis B, and healthy persons were compared by ELISA. ALR mRNA expression levels in liver tissues in some of these patients were also compared by real-time RT-PCR. Immunohistochemical analysis was carried out on HF and HCC liver tissues.

    RESULTS:Different serum ALR levels foreshowed completely different prognoses in 18 HF patients. Higher ALR levels were noted in 6 improved patients (1613.5±369.6 pmol/ml) than in 12 deteriorating patients (462.3±235.8 pmol/ml). Similar levels were found in 20 HCC patients (917.9±332. 7 pmol/ml), 24 chronic hepatitis B patients (969.2±332.5 pmol/ml) and 10 healthy persons (806.9±240.8 pmol/ml). ALR mRNA levels in HCC liver tissues [10E6.24 (1.74×106) copies/μl] were much higher than in those of HF patients receiving orthotopic liver transplantation [10E3.45 (2.82×103)copies/μl] or in healthy liver tissues [10E4.31 (2.04×104) copies/μl]. In immunohistochemical analysis, positive immunostaining in HCC liver tissue was more intense than that in HF liver tissue.

    CONCLUSION:Serum ALR level is helpful in estimating the survival time of patients with HF, and ALR may play an important role in hepatocarcinogenesis.

    (Hepatobiliary Pancreat Dis Int 2010; 9: 492-498)

    liver regeneration; expression level; hepatic failure; hepatocellular carcinoma; chronic hepatitis B

    Introduction

    Human liver diseases such as chronic hepatitis, hepatic failure (HF), and hepatocellular carcinoma (HCC) are all accompanied by hepatocyte injury and regeneration.[1]Liver regeneration is a complicated process involving many agents, and augmenter of liver regeneration (ALR) is an important polypeptide in this process. Early experiments postulated the presence of a heat-stable hepatic stimulatory substance (HSS) in the liver, since extracts from weanling or hepatectomized rat livers result in augmentation of hepatocyte proliferation. Later, the peptide purified from HSS was renamed ALR. Unlike complete mitogens such as hepatocyte growth factor (HGF) or transforming growth factor (TGF-α), ALR was defined as a co-mitogen or "secondary" mitogen.[2]It was found to be constitutively expressed in hepatocytes in an inactive form, and released from the liver after activation during regeneration. Animal research revealed changes in the level of ALR in serum at the early stage of liver regeneration, earlier than other growth factors:[3]

    after 70% hepatectomy the level of ALR in the blood rises dramatically, peaking after 12 hours. Serum ALR level well reflects hepatocyte ALR expression level and the activation of liver regeneration. Recent experiments also showed an increase of ALR expression in human liver cirrhosis and carcinoma,[4]and the suppressedexpression of ALR subsequently inhibits the growth of HepG2 cells. Anti-hALR antibody was found to partially inhibit the autonomous growth of HepG2 cells.[5,6]All the above findings confirm the relationship between ALR and hepatocyte regeneration. The balance between hepatocyte injury and regeneration determines the turnover of many liver diseases.[7]In the present study, serum ALR levels and ALR mRNA expression levels were measured in different liver diseases to determine the relationship between ALR, hepatocyte regeneration, and liver disease, especially HF and HCC.

    Methods

    The study protocols and methods were approved by the Animal Care Ethics Committee and Clinical Investigation Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (Hangzhou, China).

    Preparation of natural human ALR (nhALR) and anti-nhALR antibody

    The recombinant expression vector of pET28a(+)/ hALR was constructed, and the recombinant human ALR (rhALR) protein of about 23 kDa was expressed and purified as reported previously.[8]To obtain nhALR, an Xa-arrest Kit (Novagen Germany) was used to excise the recombined peptide part of rhALR, and the Xa protease recognized as the continuous amino acids Ile-Glu-Gly-Arg. Thus we obtained a soluble nhALR protein of about 15 kDa. Amicon Ultra-4 (Millipore, USA) was used to desalt and concentrate the protein. The concentration of the nhALR protein was determined in a SmartSpecTMplus spectrophotometer (Bio-Rad, USA) by a Bradford protein assay kit and stored at -80 ℃ until use.

    We obtained murine polyclonal antibodies against nhALR from Balb/C mice. Twenty-four female mice (8 weeks old, weighing 19-22 g) were used for immunization and they were divided into an immune group and a control group, each of 12 mice. Briefly, approximately 40 mg of nhALR protein emulsified with an equal volume of Freund's complete adjuvant (Sigma, USA) was injected at multiple intradermal sites to the immune group (nhALR was diluted to 80 mg/ml, and 0.5 ml nhALR was mixed with 0.5 ml Freund's complete adjuvant); physiologic saline was injected into the control group for negative control. The same dose of protein or physiologic saline emulsified in Freund's incomplete adjuvant was injected 2 and 4 weeks after the first injection. After 7 days, blood was collected from the eyeballs and clotted by overnight incubation at room temperature, then centrifuged at 3000 g for 15 minutes. The serum was collected and the IgG fraction was purified before use as antibodies. A Montage antibody purification kit (Millipore, USA) was used to isolate the IgG fraction from the murine antiserum. The serum was diluted with binding buffer A and loaded on a PROSEP?-A spin column to collect the IgG fraction. IgG collected from the control group was used as control antibody.

    Identification of anti-nhALR antibody by Western blotting

    nhALR protein was separated on 15% SDS-PAGE and transferred onto a 0.2 μm pore polyvinylidene fluoride membrane (Millipore USA) at 220 mA for 2 hours in a Bio-Rad Transblot electrophoretic transfer cell for Western blotting analysis. The non-specific sites were blocked with 5% nonfat milk in TBS, the membrane was washed in TBS and incubated with anti-nhALR antibody (1 μg/ml) in blocking buffer, followed by washing and incubation with horseradish peroxidase-conjugated rabbit anti-mouse immunoglobulins (1∶1000, DakoCytomation, Denmark). The ALR-anti-ALR complex was treated with a mixture of 2× stable peroxide solution and 2× luminol/enhancer solution (Novagen, Germany), and chemoluminescence was recorded on Fuju X-ray film.

    To determine whether anti-nhALR antibody combines with ALR in hepatocytes, we extracted total proteins from HepG2 cells and immortalized human hepatocytes[9]with Mammalian Protein Extraction Reagent (Pierce, America) and separated the protein on 15% denatured or natured SDS-PAGE; further detection was performed as described above.

    Enzyme-linked immunosorbent assay (ELISA)

    Serial dilutions of nhALR protein were prepared: 10 and 1 μg/ml, 100, 50, 10, 5, 2, and 1 ng/ml, and 500, 250, 125, and 62.5 pg/ml. Well plates (96 wells) were coated with anti-nhALR antibody (0.1 μg/well) in 100 μl coated buffer overnight at 4 ℃ and incubated with blocking solution (PBS containing 5% nonfat milk) at 37 ℃ for 2 hours. After washing with PBS-T, serial dilutions of nhALR protein were incubated at 37 ℃ for 1.5 hours, then anti-nhALR antibody (0.1 μg/well in 100 μl blocking solution) was added. IgG collected from the control group was used for negative control. After 2 hours incubation at room temperature, plates were rinsed three times with PBS-T, and 100 μl of 1∶2000-diluted horseradish peroxidase-conjugated rabbit anti-mouse immunoglobulins (1∶1000, DakoCytomation Denmark) was added to each well for 1 hour incubation at room temperature. After washing five times, the enzyme activity was determined by adding 100 μl of 3, 3', 5,5'-tetramethyllbenzidine substrate solution. Optical density was read at dual absorbance of 450 nm and 630 nm with an ELISA plate reader (Bio-Rad) after incubating for 10 minutes.

    Determination of ALR level in human serum by ELISA

    Human serum was obtained from 72 patients classified into 4 groups (Table 1): 20 patients with HCC, of whom 6 accepted surgical resection; 18 with HF caused by hepatitis B virus, of whom 5 received orthotopic liver transplantation (OLT); 24 with chronic hepatitis B; and 10 healthy persons without liver disease. Of the 18 HF patients, 6 were improved through artificial liver support system (ALSS) therapy and rehabilitation and left hospital after 1-2 months, whereas the other 12 deteriorated in spite of ALSS therapy (7 died and 5 received OLT). When the patients met the diagnostic criteria of HF, their serum was collected on days 1, 2, and 3 before ALSS therapy. Blood samples collected from the 72 patients were stored at room temperature overnight and centrifuged at 3000 ×g for 10 minutes to isolate the serum. ELISA detection was performed as described above.

    HCC was diagnosed pathologically and HF was diagnosed according to the clinical symptoms, laboratory results, or pathological findings. Diagnostic workup included physical examination, laboratory tests, and liver pathology according to the criteria described inLiver Diseases of the Chinese Medical Associationin 2000.

    ALR mRNA expression in liver tissue

    HCC tissues were obtained from the 6 patients with HCC who accepted surgical resection; necrotic or inflamed liver tissues from the 5 patients with HF who received OLT; and control liver tissues were from healthy donors for OLT. The operations were performed at our hospital. Informed consent to utilize the liver tissues for mRNA extraction was given by the patients or their relatives. HCC and HF were diagnosed pathologically.

    Table 1. Patient characteristics

    Real-time reverse transcriptase-polymerase chain reaction (RT-PCR)

    ALR and β-actin were synthesized in our laboratory, and their concentrations were determined by absorbance at 260 nm (SmartSpecTMplus Spectrophotometer, Bio-Rad). Ten-fold serial dilutions from 1×100 to 1×1010copies/μl were prepared.

    One hundred milligrams of each liver tissue sample was homogenized in a small earthenware basin with liquid nitrogen and total RNA was isolated using Trizol reagent as described by the manufacturer (Invitrogen. Grand Island, NY, USA). RNA concentration was determined by absorbance at 260 nm, transformed into cDNA, and stored at -80 ℃ until use.

    The level of β-actin mRNA was measured to determine the efficiency of cDNA synthesis and reverse transcription of different batches of mRNA. The PCR primers specific for ALR cDNA were 5'-TAA GGA TCC ATG CGG ACG CAG CAG AAG-3' (sense) and 5'-TAA CTC GAG CTA GTC ACA GGA GCC ATC-3' (antisense), and for β-actin cDNA 5'-GGC ATC CTC ACC CTG AAG TA-3' (sense) and 5'-TCG GGT GTT GAA GGT CTC AA-3' (antisense).

    Real-time PCR (20 μl) was performed using the SYBR Premix Ex TaqTMkit (Takara Biotechnology) in accordance with the manufacturer's protocol on an Option II real-time detection system (Bio-Rad Laboratories, Veenendaal, The Netherlands). Real-time RT-PCR data were analyzed by MJ Option MonitorTManalysis software version 3.1. The Ct value analysis, PCR efficiency, linearity, slopes of the standard curves, relative quantity of fluorescence, and dissociation curve analysis were calculated by the Strata gene software program built into the Option II apparatus.

    Immunohistochemical analysis

    The liver samples from HF and HCC patients were embedded in paraffin wax and 4-μm sections were cut. Standard pretreatment was done; anti-nhALR antibody diluted in 1∶100 in block solution was pipetted onto the sections and incubated overnight at 4 ℃, then the sections were washed three times with PBS and 1∶1000-diluted horseradish peroxidase-conjugated rabbit anti-mouse immunoglobulins were added and incubated at 37 ℃ for 1 hour. Staining was completed by diaminobenzidine (DAB) and counterstaining was with hematoxylin. The following negative controls were performed: 1) IgG collected from the Balb/C mice of the control group was used to replace the anti-nhALR antibody, and 2) anti-nhALR antibody was blocked with nhALR for 1 hour at 37 ℃ before addition.

    Statistical analysis

    Statistical analysis was performed using SPSS (version 13.0) for Windows. Student'sttest between two groups and LSDttest between several groups were used. APvalue less than 0.05 was considered statistically significant.

    Results

    rhALR and nhALR

    SDS-PAGE analysis showed the expected rhALR protein of about 23 kDa before the recombined peptide was excised, and the nhALR protein of about 15 kDa which was consistent with that reported previously (Fig. 1).

    Western blotting analysis

    Fig. 1. SDS-PAGE analysis of rhALR and nhALR. M: protein marker; lane 1: rhALR protein about 23 kDa; lane 2: nhALR protein about 15 kDa.

    Fig. 2. Western blotting analysis of nhALR and ALR in HepG2 cells/immortalized human hepatocytes. M: nhALR; lane 1: total protein extracted from immortalized human hepatocytes; lane 2: total protein extracted from HepG2 cells. A: Western blotting under denatured condition (100 mmol/L dithiothreitol, DTT); B: Western blotting under natural condition (without DTT).

    Anti-nhALR antibody immunoreacted with nhALR protein (Fig. 2). Anti-nhALR antibody-positive protein was present in the extracts prepared from both cell lines: immunoreactive protein strips of total protein extracted from HepG2 cells and immortalized human hepatocytes was about 23 kDa (denatured condition) and more than 40 kDa (dimeric structure under natural conditions) as reported previously. Thus the anti-nhALR antibody was specifically combined with ALR in HepG2 cells and ALR in human serum (Fig. 2).

    Table 2. Serum dual absorbance at 450 and 630 nm and serum ALR levels of 72 patients

    Fig. 3. Relationship between nhALR concentration and dual absorbance at 450 and 630 nm.

    Table 3. Absolute ALR and β-actin mRNA levels of 11 patients and 2 controls

    ELISA analysis

    There was a close relationship between nhALR concentration dual absorbance at 450 and 630 nm. Besides a satisfactory linear relationship from 62.5 pg/ml to 2 ng/ml was found (Fig. 3), as a good reference to analysis of the ALR concentration in patient serum.

    Determination of serum ALR levels

    The serum ALR levels of the 72 patients (Table 2) were determined by ELISA. ALR levels were calculated by dual absorbance at 450 and 630 nm according to the linear relationship (Fig. 3). ALR levels were higher in the 6 improved patients (1613.5±369.6 pmol/ml) than in the 12 deteriorating patients (462.3±235.8 pmol/ml) or the other 54 patients and healthy persons (P<0.05). ALR levels in the 12 deteriorating patients were lower than those of the other 54 patients and healthy persons (P<0.05). ALR levels were similar, in the HCC patients (917.9±332.7 pmol/ml) and chronic hepatitis B patients (969.2±332.6 pmol/ml) and higher than in the healthy persons (806.9±240.8 pmol/ml) but these findings were not statistically different (P>0.05).

    Real-time RT-PCR analysis

    The absolute ALR and β-actin mRNA levels of the 11 patients and 2 controls are listed in Table 3. The ALR expression after normalization to β-actin was much higher in HCC liver tissues [10E6.24 (1.74×106) copies/μl] than in HF receiving OLT [10E3.45 (2.82×103) copies/μl] or healthy persons [10E4.31 (2.04×104) copies/μl].

    Fig. 4. ALR protein expression in paraffin-embedded HCC and HF human liver tissue. A, B: Fields from HCC liver showing positive immunostaining of the majority of hepatocytes in cytoplasm but negative in nucleus, and rare in cholangiocytes and endothelial cells. C: Field from HF liver showing bile thrombus and less positive immunostaining than that in HCC liver sections. D, E: Negative controls (see Methods) showing lack of any positive immunostaining in hepatocytes, cholangiocytes, and endothelial cells.

    Immunohistochemical analysis

    Immunostaining was positive in the hepatocyte cytoplasm but negative in the nucleus, and rare in cholangiocytes and endothelial cells. Positive immunostaining was more intense in HCC liver tissue than in HF liver tissue. No positive immunostaining was found in negative controls (Fig. 4).

    Discussion

    ALR is a recently discovered hepatotrophic protein and unique cytokine which specifically stimulates cells of hepatic origin to grow regardless of genus.[10,11]ALR is absent from the serum of normal adult animals,[12]but a recent study[3]found that ALR is synthesized constantly in hepatocytes in an inactive form and is detected in normal adult mouse serum. Animal research found that the concentration of this factor in serum rises dramatically after 70% hepatectomy.[3]In our study, ALR was also detected in human serum, and the ALR levels in human liver diseases were significantly different. The fact that ALR is synthesized constantly and is activated during liver regeneration shows its importance in liver function and regeneration.

    The liver has extraordinary regenerative power, and adequate regeneration usually occurs in patients with acute and chronic liver diseases, although hepatocyte necrosis is extensive. However, in some lethal or acute fulminant HF, the number of regenerative hepatocytesis clearly fewer than in surviving patients, and it appears that regeneration failure causes death in such patients.[13]In our study, different serum ALR levels were found in different HF patients, and they foreshowed completely different prognoses: patients with higher serum ALR levels had liver function improved enough through ALSS therapy and rehabilitation to leave hospital; conversely, patients with lower ALR levels deteriorated to the point of death or had to receive OLT. Decreased serum ALR levels may identify patients at risk of lethal liver failure and represent the trigger for maintaining intensive medical treatment or turning to salvage liver transplantation. High serum ALR levels represent a high level of hepatocyte regeneration. The survival rates of patients with different ALR levels were statistically significant, suggesting that ALR level is helpful in estimating the survival time of patients with HF.

    HGF is another important polypeptide in the process of liver regeneration. A study found that the serum HGF level in HF patients is high,[14]and increasing HGF levels in HF patients result in deterioration, which seems opposite to our result. But we also found in surviving patients that the HGF was high at first and then decreased, while in the patients who got worse and died, the serum HGF level increased continuously. In our study, we only measured the early level of serum ALR (days 1, 2, and 3 before ALSS therapy), because all HF patients accepted ALSS therapy, and after this therapy the serum ALR level cannot reflect its real level. We found the early ALR level correlated with the prothrombin time and the prognosis. Unlike HGF, ALR is synthetized by hepatocytes, the early serum ALR level reflects the degree of regeneration of hepatocytes, and the regeneration level determines survival or death. ALR as a hepatotrophic factor takes a core place in the process of liver regeneration and may promote it by reducing liver-resident natural killer cell activity in human liver diseases.[15,16]

    HCC is now the fifth most frequent malignant tumor in the world (564 000 cases annually) and the third cause for cancer death.[17,18]There is a growing understanding of the molecular mechanisms inducing hepatocarcinogenesis, which almost never occurs in healthy liver, but the cancer risk increases sharply in response to chronic liver injury at the cirrhosis stage.[19]A detailed understanding of epidemiologic factors and molecular mechanisms associated with HCC could ultimately improve our current concepts for screening and treatment of this disease.[20]

    In our study, similar serum ALR levels were noted in HCC patients and chronic hepatitis B patients, and no significant difference was found between these patients and healthy persons. But the ALR mRNA expression levels in HCC liver tissues were higher than those in the liver tissue of healthy persons. All the above showed that ALR was expressed highly in HCC hepatocytes compared with healthy persons, but the serum ALR level in HCC patients was not high. The reason for the disparity between mRNA expression level and serum level of ALR in HCC is not yet understood. Immunohistochemical data showed that ALR existed predominantly in hepatocyte cytoplasm and positive immunostaining was more intense in HCC than in HF (which led to death). Recent research revealed that ALR stimulates the proliferation of HepG2 and QGY cells dose-dependentlyin vitro, but has no influence on the proliferation of primary rat hepatocytes. The expression of ALR is much higher in HCC liver tissues than in normal liver tissues, and it is not related to the differentiation and size of the carcinoma.[21]Another study also found that hALR is highly expressed by HepG2 cells and maintains the autonomous growth of hepatoma cellsin vitrothrough an autocrine mechanism, and anti-hALR antibody partly inhibits the autonomous growth of HepG2 cellsin vitro. The short interfering RNA targeting hALR gene specifically suppresses the expression of hALR, and subsequently inhibits the growth of HepG2 cells.[5,6]ALR might play an important role in the occurrence and development of HCC. The findings suggest an important role for ALR in hepatocarcinogenesis and therefore its potential value in clinical diagnosis and therapy of HCC.

    Because of the core place of ALR in liver function and regeneration, and its close relationship with human liver diseases such as HF and HCC, there is an increasing necessity to extend research on mammalian ALR protein in different patients with different kinds of liver diseases or at different stages of hepatitis.

    Funding:This work was supported by grants from the National Natural Science Foundation of China (30972592 and 30970747), and Zhejiang Provincial Natural Science Foundation (Y2090010).Ethical approval:Not needed.

    Contributors:SJF and LJ proposed the study. YHY wrote the first draft. XDR analyzed the data. All authors contributed to the design and interpretation of the study and to further drafts. SJF is the guarantor.

    Competing interest:No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

    1 Pawlowski R, Jura J. ALR and liver regeneration. Mol Cell Biochem 2006;288:159-169.

    2 de Juan C, Benito M, Alvarez A, Fabregat I. Differential proliferative response of cultured fetal and regenerating hepatocytes to growth factors and hormones. Exp Cell Res 1992;202:495-500.

    3 Gandhi CR, Kuddus R, Subbotin VM, Prelich J, Murase N, Rao AS, et al. A fresh look at augmenter of liver regeneration in rats. Hepatology 1999;29:1435-1445.

    4 Thasler WE, Schlott T, Thelen P, Hellerbrand C, Bataille F, Lichtenauer M, et al. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. Histopathology 2005;47:57-66.

    5 Tang L, Sun H, Zhang L, Guo H, Zhang L, Liu Q. Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2. Ai Zheng 2006;25:671-676.

    6 Tang L, Sun H, Zhang L, Guo H, Chen XH, Deng JC, et al. Effects of anti-human augmenter of liver regeneration monoclonal antibody on proliferation of HepG2 cellsin vitro. J Chongqing Med Univ 2005;30:7-9, 17.

    7 Elias E. Liver failure and liver disease. Hepatology 2006;43: S239-242.

    8 Sheng J, Yu H, Li J, Sheng G, Zhou L, Lu Y. Cloning and expression of the human augmenter of liver regeneration at low temperature in Escherichia coli. J Biochem Biophys Methods 2007;70:465-470.

    9 Li J, Li LJ, Cao HC, Sheng GP, Yu HY, Xu W, et al. Establishment of highly differentiated immortalized human hepatocyte line with simian virus 40 large tumor antigen for liver based cell therapy. ASAIO J 2005;51:262-268.

    10 LaBrecque DR, Pesch LA. Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol 1975;248:273-284.

    11 Hagiya M, Francavilla A, Polimeno L, Ihara I, Sakai H, Seki T, et al. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A 1994;91:8142-8146.

    12 Giorda R, Hagiya M, Seki T, Shimonishi M, Sakai H, Michaelson J, et al. Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol Med 1996;2:97-108.

    13 Riordan SM, Williams R. Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin Liver Dis 2003;23:203-215.

    14 Schirmacher P, Geerts A, Pietrangelo A, Dienes HP, Rogler CE. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology 1992;15:5-11.

    15 Vujanovic NL, Polimeno L, Azzarone A, Francavilla A, Chambers WH, Starzl TE, et al. Changes of liver-resident NK cells during liver regeneration in rats. J Immunol 1995;154: 6324-6238.

    16 Tanigawa K, Sakaida I, Masuhara M, Hagiya M, Okita K. Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases. J Gastroenterol 2000;35:112-119.

    17 Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35: 519-524.

    18 Campbell JS, Johnson MM, Bauer RL, Hudkins KL, Gilbertson DG, Riehle KJ, et al. Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis. Differentiation 2007;75:843-852.

    19 Fausto N, Webber EM. Mechanisms of growth regulation in liver regeneration and hepatic carcinogenesis. Prog Liver Dis 1993;11:115-137.

    20 El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-2576.

    21 Sun H, Yu HF, Wu CX, Guan XQ, Liu Q. Expression of augmenter of liver regeneration in hepatic tumor cells and its clinical significance. Zhonghua Gan Zang Bing Za Zhi 2005; 13:205-208.

    January 15, 2010

    Accepted after revision April 27, 2010

    Author Affiliations: State Key Laboratory of Infectious Disease and Department of Infectious Disease, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China (Yu HY, Xiang DR, Huang HJ, Li J and Sheng JF)

    Ji-Fang Sheng, MD, PhD, Department of Infectious Disease, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China (Tel: 86-571-87236759; Fax: 86-571-87236755; Email: sania8@163.com)

    ? 2010, Hepatobiliary Pancreat Dis Int. All rights reserved.

    老司机影院成人| 捣出白浆h1v1| 美女大奶头黄色视频| 少妇人妻 视频| 青春草亚洲视频在线观看| xxxhd国产人妻xxx| 观看美女的网站| 中文精品一卡2卡3卡4更新| 亚洲精品国产色婷婷电影| 精品久久国产蜜桃| 日本wwww免费看| 日本与韩国留学比较| 国产成人精品久久久久久| 大话2 男鬼变身卡| 五月开心婷婷网| 热99久久久久精品小说推荐| 免费人成在线观看视频色| 国产亚洲精品第一综合不卡 | 国产av精品麻豆| 久久99一区二区三区| 日韩精品有码人妻一区| 一二三四中文在线观看免费高清| 高清毛片免费看| 久久久久精品人妻al黑| 免费在线观看黄色视频的| 久久人人爽av亚洲精品天堂| 亚洲精品456在线播放app| 日韩在线高清观看一区二区三区| 中文欧美无线码| 国产高清国产精品国产三级| 一边摸一边做爽爽视频免费| 亚洲性久久影院| 亚洲av国产av综合av卡| 黄片播放在线免费| 欧美成人精品欧美一级黄| 伦精品一区二区三区| 亚洲av国产av综合av卡| 黄色怎么调成土黄色| 建设人人有责人人尽责人人享有的| 日韩人妻精品一区2区三区| 国产一区二区在线观看av| 一区二区三区四区激情视频| 九九爱精品视频在线观看| 免费大片黄手机在线观看| 只有这里有精品99| 久久精品久久精品一区二区三区| 天堂俺去俺来也www色官网| 成年av动漫网址| 欧美国产精品va在线观看不卡| 大码成人一级视频| 国产精品一区www在线观看| 天天躁夜夜躁狠狠躁躁| 熟女av电影| 99国产综合亚洲精品| 国产精品人妻久久久久久| av.在线天堂| 美女主播在线视频| 成人漫画全彩无遮挡| 精品久久久精品久久久| 人妻人人澡人人爽人人| 午夜精品国产一区二区电影| 80岁老熟妇乱子伦牲交| 国产高清不卡午夜福利| 国产麻豆69| 搡老乐熟女国产| 最后的刺客免费高清国语| 久久精品久久久久久久性| 国产又爽黄色视频| 伦理电影大哥的女人| 男女下面插进去视频免费观看 | 五月天丁香电影| 亚洲精品国产av蜜桃| 秋霞伦理黄片| 久久99一区二区三区| 菩萨蛮人人尽说江南好唐韦庄| 国产高清国产精品国产三级| 男人爽女人下面视频在线观看| 丝瓜视频免费看黄片| a级片在线免费高清观看视频| av.在线天堂| av福利片在线| 一级毛片电影观看| 在线 av 中文字幕| 一级爰片在线观看| 中文字幕另类日韩欧美亚洲嫩草| 日韩制服骚丝袜av| 男男h啪啪无遮挡| 久久精品久久久久久久性| 在线观看人妻少妇| 国产成人一区二区在线| 91午夜精品亚洲一区二区三区| 亚洲美女视频黄频| 午夜免费鲁丝| av女优亚洲男人天堂| 99热6这里只有精品| 又黄又爽又刺激的免费视频.| 国产在线视频一区二区| 一区二区三区精品91| 国产一区亚洲一区在线观看| 国产免费一区二区三区四区乱码| 男人舔女人的私密视频| 国产又色又爽无遮挡免| 你懂的网址亚洲精品在线观看| 美女大奶头黄色视频| 成人18禁高潮啪啪吃奶动态图| 国产亚洲精品久久久com| 亚洲精品456在线播放app| 久热这里只有精品99| 大陆偷拍与自拍| 日韩精品有码人妻一区| 黄色毛片三级朝国网站| 超碰97精品在线观看| 日韩电影二区| 免费观看av网站的网址| 国产成人免费观看mmmm| 亚洲国产最新在线播放| 美女视频免费永久观看网站| 国产探花极品一区二区| 最新的欧美精品一区二区| 最近最新中文字幕免费大全7| 男女高潮啪啪啪动态图| 一区二区三区乱码不卡18| 日韩一区二区三区影片| 色婷婷久久久亚洲欧美| 成人国产av品久久久| 女人被躁到高潮嗷嗷叫费观| 嫩草影院入口| 亚洲国产av影院在线观看| 最新的欧美精品一区二区| 国产女主播在线喷水免费视频网站| 国产精品一区二区在线观看99| 大香蕉久久网| 99精国产麻豆久久婷婷| 日韩不卡一区二区三区视频在线| 久久韩国三级中文字幕| 成年av动漫网址| 黄色配什么色好看| 国产 一区精品| 搡老乐熟女国产| 熟女人妻精品中文字幕| 久久婷婷青草| 亚洲精品乱码久久久久久按摩| xxx大片免费视频| 国产免费一区二区三区四区乱码| 欧美成人午夜免费资源| 香蕉丝袜av| 日韩中字成人| 亚洲 欧美一区二区三区| 我要看黄色一级片免费的| 中文字幕免费在线视频6| 亚洲精品一区蜜桃| 最近中文字幕2019免费版| 久久久久视频综合| 最近2019中文字幕mv第一页| 丝袜喷水一区| 亚洲久久久国产精品| 超色免费av| av一本久久久久| 美女国产高潮福利片在线看| av黄色大香蕉| 亚洲成色77777| 街头女战士在线观看网站| 国产激情久久老熟女| av卡一久久| 中文字幕亚洲精品专区| 黄色一级大片看看| 欧美日韩视频精品一区| 黄色毛片三级朝国网站| 国产乱人偷精品视频| 国产一区二区激情短视频 | 91精品三级在线观看| 久久99一区二区三区| 精品一区二区免费观看| av国产精品久久久久影院| 久久人人爽人人片av| 秋霞伦理黄片| 中文欧美无线码| 国产男女内射视频| 性色av一级| 99九九在线精品视频| 成人无遮挡网站| 欧美 日韩 精品 国产| 男人添女人高潮全过程视频| 最近中文字幕2019免费版| 少妇人妻久久综合中文| 欧美人与性动交α欧美软件 | 亚洲av欧美aⅴ国产| 日韩不卡一区二区三区视频在线| 色视频在线一区二区三区| 欧美97在线视频| 成人毛片a级毛片在线播放| 青春草亚洲视频在线观看| 又黄又粗又硬又大视频| 纯流量卡能插随身wifi吗| 美女脱内裤让男人舔精品视频| 久久久久久伊人网av| 青青草视频在线视频观看| 国产精品久久久久久精品古装| 18+在线观看网站| 纵有疾风起免费观看全集完整版| 免费不卡的大黄色大毛片视频在线观看| 精品卡一卡二卡四卡免费| 美女视频免费永久观看网站| 免费看光身美女| 亚洲精品乱码久久久久久按摩| 国产av国产精品国产| 中文字幕亚洲精品专区| 大陆偷拍与自拍| 久久午夜综合久久蜜桃| 免费看av在线观看网站| 亚洲国产日韩一区二区| 欧美日韩精品成人综合77777| 看免费av毛片| 男女无遮挡免费网站观看| 一级毛片黄色毛片免费观看视频| 各种免费的搞黄视频| 一本大道久久a久久精品| 日韩在线高清观看一区二区三区| 最新的欧美精品一区二区| 国产男人的电影天堂91| 丝瓜视频免费看黄片| 你懂的网址亚洲精品在线观看| 日本vs欧美在线观看视频| 卡戴珊不雅视频在线播放| 成年动漫av网址| 国产永久视频网站| 夫妻午夜视频| 免费看av在线观看网站| 免费女性裸体啪啪无遮挡网站| 成人国产av品久久久| 亚洲欧洲精品一区二区精品久久久 | 亚洲精品国产色婷婷电影| a级毛色黄片| 亚洲,欧美精品.| 成人手机av| 亚洲精品av麻豆狂野| 亚洲国产成人一精品久久久| 免费观看在线日韩| 最近中文字幕高清免费大全6| 18禁观看日本| 人人妻人人澡人人爽人人夜夜| 菩萨蛮人人尽说江南好唐韦庄| av卡一久久| av在线app专区| 国产精品久久久久久久电影| 丰满乱子伦码专区| 在线免费观看不下载黄p国产| 国产精品人妻久久久久久| 丝袜人妻中文字幕| 国产成人av激情在线播放| 激情视频va一区二区三区| 人妻一区二区av| 一区二区三区精品91| 中文字幕av电影在线播放| 在线亚洲精品国产二区图片欧美| 永久免费av网站大全| 一级毛片电影观看| 美女视频免费永久观看网站| 夫妻性生交免费视频一级片| 国产高清国产精品国产三级| 啦啦啦啦在线视频资源| videosex国产| 亚洲欧洲日产国产| 成人18禁高潮啪啪吃奶动态图| 久久精品国产亚洲av天美| 成人亚洲精品一区在线观看| 各种免费的搞黄视频| 亚洲欧美一区二区三区国产| 国产成人一区二区在线| 中国三级夫妇交换| av女优亚洲男人天堂| 国产成人精品无人区| 精品国产一区二区久久| 国产精品嫩草影院av在线观看| 精品一品国产午夜福利视频| 一区在线观看完整版| av国产久精品久网站免费入址| 午夜影院在线不卡| 国产精品偷伦视频观看了| av女优亚洲男人天堂| 久久精品国产亚洲av涩爱| 69精品国产乱码久久久| 麻豆乱淫一区二区| 亚洲成色77777| 亚洲av电影在线观看一区二区三区| 韩国精品一区二区三区 | 一本大道久久a久久精品| 午夜免费观看性视频| 91国产中文字幕| 91精品国产国语对白视频| 乱码一卡2卡4卡精品| 日本黄大片高清| av天堂久久9| 香蕉精品网在线| 成人免费观看视频高清| 日韩中文字幕视频在线看片| 亚洲人与动物交配视频| 人成视频在线观看免费观看| 亚洲高清免费不卡视频| 国产成人一区二区在线| 久久久久人妻精品一区果冻| 亚洲三级黄色毛片| 午夜av观看不卡| 中文字幕精品免费在线观看视频 | 久久青草综合色| 美女中出高潮动态图| 2022亚洲国产成人精品| 久久精品国产综合久久久 | 亚洲精品久久久久久婷婷小说| 久久综合国产亚洲精品| 高清在线视频一区二区三区| 国产黄频视频在线观看| av国产久精品久网站免费入址| 少妇的逼水好多| av又黄又爽大尺度在线免费看| 51国产日韩欧美| 捣出白浆h1v1| av片东京热男人的天堂| 激情视频va一区二区三区| 久久久久久久久久人人人人人人| 亚洲精品av麻豆狂野| 日日啪夜夜爽| 人人妻人人澡人人看| 色婷婷久久久亚洲欧美| 日韩熟女老妇一区二区性免费视频| 日韩中文字幕视频在线看片| 国产乱来视频区| 一级,二级,三级黄色视频| 久久青草综合色| 欧美97在线视频| 日韩三级伦理在线观看| 三上悠亚av全集在线观看| 满18在线观看网站| 多毛熟女@视频| 亚洲五月色婷婷综合| 在线天堂最新版资源| 国产成人a∨麻豆精品| 80岁老熟妇乱子伦牲交| 成人国语在线视频| 乱人伦中国视频| 一级,二级,三级黄色视频| 草草在线视频免费看| 美国免费a级毛片| 午夜免费男女啪啪视频观看| 十分钟在线观看高清视频www| 内地一区二区视频在线| 国产极品天堂在线| 一本久久精品| 国产免费现黄频在线看| 日韩成人av中文字幕在线观看| 狂野欧美激情性bbbbbb| 国产福利在线免费观看视频| 男男h啪啪无遮挡| 免费看不卡的av| 国产片内射在线| 涩涩av久久男人的天堂| 久久99蜜桃精品久久| 国产精品一二三区在线看| 国产高清不卡午夜福利| 亚洲色图综合在线观看| 国产成人精品福利久久| 免费av中文字幕在线| 久久久久久久大尺度免费视频| 久久99蜜桃精品久久| 国语对白做爰xxxⅹ性视频网站| 亚洲精华国产精华液的使用体验| 国产精品三级大全| 国产成人精品一,二区| 久久99精品国语久久久| 欧美日韩av久久| 99re6热这里在线精品视频| 桃花免费在线播放| 三上悠亚av全集在线观看| 日韩av不卡免费在线播放| 少妇猛男粗大的猛烈进出视频| 久久久欧美国产精品| 国产成人免费观看mmmm| 久久久久久人妻| 视频在线观看一区二区三区| 日本欧美国产在线视频| 久久久久久久久久久久大奶| 卡戴珊不雅视频在线播放| 宅男免费午夜| 高清av免费在线| 丝瓜视频免费看黄片| 最新的欧美精品一区二区| 中文字幕最新亚洲高清| 午夜视频国产福利| 国产成人精品婷婷| 久久精品国产a三级三级三级| 午夜日本视频在线| 亚洲精品国产av成人精品| 国产在线视频一区二区| 国产亚洲午夜精品一区二区久久| 国产日韩欧美在线精品| 777米奇影视久久| 老熟女久久久| 国产精品一国产av| 国内精品宾馆在线| 一级毛片电影观看| 日韩视频在线欧美| 18禁裸乳无遮挡动漫免费视频| 久久久久国产精品人妻一区二区| videosex国产| 亚洲av.av天堂| 国产在视频线精品| 国产探花极品一区二区| 在线观看免费日韩欧美大片| 成人影院久久| 精品亚洲成a人片在线观看| 欧美最新免费一区二区三区| 精品人妻偷拍中文字幕| 观看av在线不卡| 国产视频首页在线观看| 久久久久久人人人人人| 精品国产一区二区三区久久久樱花| 精品亚洲乱码少妇综合久久| 亚洲精华国产精华液的使用体验| 中文字幕av电影在线播放| 九草在线视频观看| 精品国产国语对白av| 国产乱人偷精品视频| 日韩av在线免费看完整版不卡| 国产日韩欧美视频二区| 寂寞人妻少妇视频99o| 国产免费视频播放在线视频| 久久人人爽人人爽人人片va| a级毛色黄片| 一区在线观看完整版| 人人妻人人澡人人爽人人夜夜| 亚洲av男天堂| 久久人人爽人人爽人人片va| 日韩 亚洲 欧美在线| 亚洲成av片中文字幕在线观看 | 男女啪啪激烈高潮av片| 全区人妻精品视频| 国产精品国产三级国产av玫瑰| 全区人妻精品视频| 高清视频免费观看一区二区| 亚洲精品456在线播放app| 午夜福利网站1000一区二区三区| 一本一本久久a久久精品综合妖精 国产伦在线观看视频一区 | 免费女性裸体啪啪无遮挡网站| 亚洲美女视频黄频| 亚洲国产av新网站| 日本欧美国产在线视频| 国产有黄有色有爽视频| 嫩草影院入口| 老司机影院成人| 黑丝袜美女国产一区| 黄色怎么调成土黄色| 亚洲欧美成人精品一区二区| www.色视频.com| 亚洲国产精品成人久久小说| 国产黄频视频在线观看| 久久精品国产综合久久久 | 午夜激情久久久久久久| 成人二区视频| 大话2 男鬼变身卡| 国产 一区精品| 热re99久久国产66热| 男女午夜视频在线观看 | 日日撸夜夜添| 欧美日韩视频高清一区二区三区二| 亚洲三级黄色毛片| 五月玫瑰六月丁香| 香蕉精品网在线| 久久久久久久久久人人人人人人| 有码 亚洲区| 中国国产av一级| 麻豆乱淫一区二区| 在线亚洲精品国产二区图片欧美| 亚洲熟女精品中文字幕| 欧美成人精品欧美一级黄| av免费观看日本| av电影中文网址| a级毛片在线看网站| 韩国av在线不卡| 日韩av不卡免费在线播放| 香蕉精品网在线| 下体分泌物呈黄色| 国产福利在线免费观看视频| 七月丁香在线播放| 精品人妻在线不人妻| 91在线精品国自产拍蜜月| 97在线人人人人妻| 亚洲精品视频女| 狠狠精品人妻久久久久久综合| 肉色欧美久久久久久久蜜桃| 最后的刺客免费高清国语| 久久免费观看电影| 在线免费观看不下载黄p国产| 亚洲国产精品一区二区三区在线| 性色av一级| av播播在线观看一区| 欧美人与性动交α欧美软件 | 亚洲美女视频黄频| 在线免费观看不下载黄p国产| 亚洲成色77777| 国产精品一区www在线观看| 国产白丝娇喘喷水9色精品| 久久ye,这里只有精品| 久久久久久久久久成人| 视频中文字幕在线观看| 日本黄色日本黄色录像| 国产精品欧美亚洲77777| 亚洲三级黄色毛片| 久久久久视频综合| 日韩精品免费视频一区二区三区 | 国产福利在线免费观看视频| 国产精品一区www在线观看| 欧美人与性动交α欧美精品济南到 | 国产国语露脸激情在线看| 亚洲伊人色综图| 亚洲美女视频黄频| 亚洲人与动物交配视频| 国产精品无大码| 香蕉精品网在线| 哪个播放器可以免费观看大片| 丝袜脚勾引网站| 波野结衣二区三区在线| 91久久精品国产一区二区三区| 97在线人人人人妻| 午夜福利网站1000一区二区三区| 国产av国产精品国产| 深夜精品福利| 亚洲精品久久午夜乱码| 日韩熟女老妇一区二区性免费视频| 欧美国产精品一级二级三级| 午夜免费观看性视频| 亚洲av成人精品一二三区| 秋霞在线观看毛片| 汤姆久久久久久久影院中文字幕| 三级国产精品片| 日本与韩国留学比较| 秋霞在线观看毛片| 黄片无遮挡物在线观看| 十八禁高潮呻吟视频| 一级毛片 在线播放| 精品亚洲成国产av| 国产精品国产三级国产av玫瑰| 日韩视频在线欧美| 亚洲国产av影院在线观看| 国产精品人妻久久久久久| 久久青草综合色| 岛国毛片在线播放| 美女xxoo啪啪120秒动态图| 亚洲,欧美精品.| 最近中文字幕高清免费大全6| 最近最新中文字幕大全免费视频 | 久久这里只有精品19| 免费高清在线观看视频在线观看| 精品亚洲成国产av| 天美传媒精品一区二区| 亚洲欧美精品自产自拍| 中文字幕制服av| 多毛熟女@视频| 久久女婷五月综合色啪小说| 国产乱来视频区| 一本—道久久a久久精品蜜桃钙片| 久久亚洲国产成人精品v| 日韩欧美精品免费久久| 汤姆久久久久久久影院中文字幕| 在线观看人妻少妇| xxxhd国产人妻xxx| 成人亚洲精品一区在线观看| 婷婷色综合www| 国产精品 国内视频| 天堂俺去俺来也www色官网| 制服诱惑二区| 日韩一区二区三区影片| 免费高清在线观看视频在线观看| 国产精品国产三级国产专区5o| 永久免费av网站大全| 一二三四中文在线观看免费高清| 国产亚洲精品第一综合不卡 | 亚洲 欧美一区二区三区| 成年动漫av网址| 高清黄色对白视频在线免费看| 国产视频首页在线观看| 各种免费的搞黄视频| 国产亚洲一区二区精品| 天天操日日干夜夜撸| 久久国产亚洲av麻豆专区| 精品人妻一区二区三区麻豆| 欧美日韩视频精品一区| 熟女人妻精品中文字幕| 久久99一区二区三区| 中文字幕av电影在线播放| 欧美变态另类bdsm刘玥| 久久久久久伊人网av| 51国产日韩欧美| www.av在线官网国产| 国产精品免费大片| 国产在视频线精品| h视频一区二区三区| 亚洲欧美成人综合另类久久久| 欧美精品亚洲一区二区| videos熟女内射| 国产精品成人在线| 51国产日韩欧美| 狠狠婷婷综合久久久久久88av| 午夜免费鲁丝| 国产xxxxx性猛交| 少妇人妻久久综合中文| 97精品久久久久久久久久精品| 97在线人人人人妻| 黄片无遮挡物在线观看| 高清欧美精品videossex| 国产白丝娇喘喷水9色精品| 精品第一国产精品| 日韩精品免费视频一区二区三区 | 午夜福利视频在线观看免费| av福利片在线| 51国产日韩欧美|